课题基金 / 基金详情

Risk of recurrence after diagnosis of invasive breast cancer by molecular subtype as defined by ER, PR and her2 status

Risk of recurrence after diagnosis of invasive breast cancer by molecular subtype as defined by ER, PR and her2 status
根据 ER、PR 和 her2 状态定义的分子亚型诊断浸润性乳腺癌后的复发风险
批准号：
nhmrc : 1029903
负责人：
Dr Laura Baglietto
金额：
$33.38万
依托单位：
Cancer Council Victoria
依托单位国家：
澳大利亚
项目类别：
Project Grants
财政年份：
2012
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2012-01-01 至 2015-12-31
来源：
https://researchdata.edu.au/risk-recurrence-diagnosis-her2-status/110718
关键词：
Riskrecurrenceafterdiagnosisinvasive

项目摘要

项目成果

Dr Laura Baglietto的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Breast cancer is a heterogeneous disease. Molecular subtypes have been identified that differ in terms of prognosis and response to treatment. This study aims to estimate recurrence free survival of breast cancer by molecular subtypes in a population-based sample of Australian women. The results will assist clinicians to guide their therapeutic decisions and will inform women about their anticipated outcome after diagnosis of breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Methylation as a risk and prognostic factor for breast cancer
  • 批准号：
    nhmrc : 1011618
  • 项目类别：
    NHMRC Project Grants
  • 资助金额：
    $39.67万
  • 财政年份：
    2011
  • 负责人：
    Dr Laura Baglietto
  • 依托单位：
    Cancer Council Victoria
Vitamin D and risk of cancer and mortality in the Melbourne Collaborative Cohort Study
  • 批准号：
    nhmrc : 623208
  • 项目类别：
    NHMRC Project Grants
  • 资助金额：
    $34.66万
  • 财政年份：
    2010
  • 负责人：
    Dr Laura Baglietto
  • 依托单位：
    Cancer Council Victoria
Germline mutations in mismatch repair genes: prevalence, risk of cancer, and environmental modifiers of risk.
  • 批准号：
    nhmrc : 400160
  • 项目类别：
    NHMRC Project Grants
  • 资助金额：
    $14.45万
  • 财政年份：
    2006
  • 负责人：
    Dr Laura Baglietto
  • 依托单位：
    The University of Melbourne
海外基金